M Health Fairview - Maple Grove Mayo Clinic College of Medicine North Oaks, Minnesota
Learning Objectives:
Evaluate the latest clinical data, mechanisms of action, and pharmacokinetics of newer and emerging ADC therapies for the treatment of hematologic malignancies
Apply current guidelines and the latest evidence when assessing candidates and sequencing considerations for ADC therapy in hematologic malignancies
Assess toxicity profiles to understand how to manage AEs and DDIs associated with ADC therapy in hematologic malignancies